Delivery Order SPE2DB25D3020-SPE2DB26FWGCM
- Not listed
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Ingrezza 40 mg on September 17, 2025, with completion scheduled for October 8, 2025. This competitive, non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,027.70 to AmerisourceBergen Drug Corp for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed price contract. The award was issued on September 18, 2025, with an ultimate completion date of October 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Ingrezza 80 mg capsules (30-count units) under a firm fixed-price arrangement. The contract ceiling value is $12,083.10, with an ultimate completion date of October 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a total value of...
- The Defense Logistics Agency awarded a competitively competed delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Ingrezza 40 mg capsules (30-count packages) valued at $11,622.18, with completion required by December 1, 2025. This firm fixed price delivery order represents a non-set-aside award and will be fulfilled from the vendor's corporate office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,027.70 for Ingrezza 80 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ingrezza is a prescription medication used to treat tardive dyskinesia, a movement disorder, and represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,027.70 to supply Ingrezza 80 mg capsules (30-count packaging) with a firm fixed price structure. The award, issued on August 5, 2025, is scheduled for completion by August 26, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $7,352.24 to AmerisourceBergen Drug Corp for the supply of Ingrezza 40 mg capsules (30-count units). This firm fixed price, non-competitive delivery order was awarded on August 4, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Ingrezza is a specialized neurological medication used in the treatment of tardive dyskinesia,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ingrezza 60 mg capsules (30-count package) valued at $8,099.22 with a firm fixed price structure. The delivery order, which represents a non-competitive set-aside award, is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's operations in Conshohocken, Pennsylvania. This contract represents a child ordering...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) with a ceiling value of $3,676.12. This is a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs...
- The Defense Logistics Agency awarded a $4,027.70 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Ingrezza 80 mg capsules (30-count units). This non-set-aside, firm fixed-price contract represents a competitive award to support federal medical procurement needs. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This delivery order falls under...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB26FWGCMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). The order represents a non-competitive, firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Performance will be completed by December 3, 2025, with fulfillment occurring at the contractor's Conshohocken, Pennsylvania facility. Ingrezza is a prescription antipsychotic medication used in the treatment of tardive dyskinesia and other neurological conditions, reflecting the broad pharmaceutical portfolio that AmerisourceBergen supplies to federal medical systems. This delivery order is issued under AmerisourceBergen's prime IDC with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support contract through December 2026 that enables the company to supply medications, vaccines, medical devices, and related commodities to military healthcare programs worldwide. As one of the nation's largest pharmaceutical distributors, AmerisourceBergen leverages this strategic vehicle to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract demonstrates the company's established capability to meet federal procurement requirements and its role as a critical vendor for military medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/10/25 |